Gary A. Lyons

Insider Reports History

Entity
Individual
Location
12790 El Camino Real, C/O Neurocrine Biosciences, San Diego, CA
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gary A. Lyons:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NEUROCRINE BIOSCIENCES INC Director Common Stock 119K $17.9M $150.43 Aug 13, 2024 Direct
Travere Therapeutics, Inc. Director Common Stock 51K $773K $15.15 Oct 4, 2024 Direct
Eledon Pharmaceuticals, Inc. Director Common Stock 150K $674K $4.48 May 1, 2023 Direct
NEUROCRINE BIOSCIENCES INC Director Restricted Stock Unit 1.44K $204K $141.90 May 22, 2024 Direct
RIGEL PHARMACEUTICALS INC Director Common Stock 75K $131K $1.75 May 26, 2023 Direct
NEUROCRINE BIOSCIENCES INC Director Non-Qualified Stock Option 0 $0 $73.60 Aug 13, 2024 Direct
Brickell Biotech, Inc. Director Stock Option (right to buy) 65K May 17, 2022 Direct
RIGEL PHARMACEUTICALS INC Director Stock Option (Right to Buy) 30K May 26, 2023 Direct
Travere Therapeutics, Inc. Director Stock option (right to buy) 0 Oct 4, 2024 Direct

Insider Reports Filed by Gary A. Lyons

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TVTX Travere Therapeutics, Inc. Oct 4, 2024 4 -$170K 4 Oct 4, 2024 Director
NBIX NEUROCRINE BIOSCIENCES INC Aug 13, 2024 3 -$1.25M 4 Aug 15, 2024 Director
NBIX NEUROCRINE BIOSCIENCES INC Jul 16, 2024 3 -$99.8K 4 Jul 18, 2024 Director
NBIX NEUROCRINE BIOSCIENCES INC May 22, 2024 2 $0 4 May 23, 2024 Director
NBIX NEUROCRINE BIOSCIENCES INC May 17, 2024 2 $0 4 May 21, 2024 Director
NBIX NEUROCRINE BIOSCIENCES INC May 14, 2024 3 -$1.7M 4 May 16, 2024 Director
TVTX Travere Therapeutics, Inc. May 8, 2024 2 $0 4 May 10, 2024 Director
NBIX NEUROCRINE BIOSCIENCES INC Dec 22, 2023 1 -$1.3M 4 Dec 27, 2023 Director
NBIX NEUROCRINE BIOSCIENCES INC Dec 1, 2023 3 -$584K 4 Dec 5, 2023 Director
NBIX NEUROCRINE BIOSCIENCES INC Sep 12, 2023 3 -$575K 4 Sep 14, 2023 Director
NBIX NEUROCRINE BIOSCIENCES INC Sep 1, 2023 3 -$550K 4 Sep 6, 2023 Director
RIGL RIGEL PHARMACEUTICALS INC May 26, 2023 2 $0 4 Jul 12, 2023 Director
NBIX NEUROCRINE BIOSCIENCES INC May 17, 2023 2 $0 4 May 19, 2023 Director
TVTX Travere Therapeutics, Inc. May 17, 2023 2 $0 4 May 19, 2023 Director
ELDN Eledon Pharmaceuticals, Inc. May 1, 2023 1 $0 4 May 2, 2023 Director
ELDN Eledon Pharmaceuticals, Inc. Feb 1, 2023 1 $0 4 Feb 2, 2023 Director
NBIX NEUROCRINE BIOSCIENCES INC Oct 31, 2022 3 -$1.72M 4 Nov 2, 2022 Director
NBIX NEUROCRINE BIOSCIENCES INC Oct 4, 2022 1 -$553K 4 Oct 5, 2022 Director
RIGL RIGEL PHARMACEUTICALS INC May 20, 2022 2 $0 4 May 23, 2022 Director
NBIX NEUROCRINE BIOSCIENCES INC May 18, 2022 1 $0 4 May 20, 2022 Director
FRTX Brickell Biotech, Inc. May 17, 2022 1 $0 4 May 17, 2022 Director
TVTX Travere Therapeutics, Inc. May 11, 2022 2 $0 4 May 12, 2022 Director
NBIX NEUROCRINE BIOSCIENCES INC Apr 25, 2022 3 -$1.39M 4 Apr 27, 2022 Director
ELDN Eledon Pharmaceuticals, Inc. Feb 1, 2022 1 $0 4 Feb 2, 2022 Director
NBIX NEUROCRINE BIOSCIENCES INC Oct 7, 2021 1 -$525K 4 Oct 12, 2021 Director
FRTX Brickell Biotech, Inc. Jun 14, 2021 1 $0 4 Jun 14, 2021 Director
NBIX NEUROCRINE BIOSCIENCES INC Jun 10, 2021 1 -$1M 4 Jun 14, 2021 Director
RIGL RIGEL PHARMACEUTICALS INC May 19, 2021 2 $0 4 May 21, 2021 Director
NBIX NEUROCRINE BIOSCIENCES INC May 19, 2021 1 $0 4 May 20, 2021 Director
TVTX Travere Therapeutics, Inc. May 14, 2021 2 $0 4 May 18, 2021 Director